4 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Cholinergic Urticaria: new trials by email Literature Review of Cholinergic Urticaria trials Research Report on Cholinergic Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identification of Subpopulations of Patients With Cholinergic Urticaria Based on Infrared Exposure Test Results. Infrared exposure test - Cholinergic Urticaria | Not applicable | Not yet recruiting | University Hospital, Montpellier | 50 | 2025-05-30 | 2025-04-29 |
| Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic Urticaria serum levels of Janus Kinase 1and 2 - Cholinergic Urticaria | Not applicable | Unknown | Sohag University | 90 | 2023-12-15 | 2024-01-11 |
| Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria LEO 152020, LEO 152020 placebo - Cholinergic Urticaria | Phase 2 | Completed | JW Pharmaceutical | 20 | 2021-05-10 | 2024-04-22 |
| A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria CDX-0159 - Cold Urticaria, Cold Contact Urticaria | Phase 1 | Completed | Celldex Therapeutics | 41 | 2020-11-24 | 2023-05-17 |
| Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria Ligelizumab, Placebo - Chronic Spontaneous Urticaria, Cholinergic Urticaria | Phase 1 | Terminated | Novartis Pharmaceuticals | 11 | 2020-08-05 | 2024-06-18 |
| Cholinergic Urticaria - Efficacy of Dupilumab Dupilumab, Placebo - Cholinergic Urticaria | Phase 2 | Completed | Charite University, Berlin, Germany | 48 | 2018-12-10 | 2023-09-06 |
| Efficacy Study of Omalizumab in Cholinergic Urticaria Active, Placebo, Open labeled - Cholinergic Urticaria | Phase 2 | Completed | Clinica Universidad de Navarra, Universidad de Navarra | 24 | 2014-01-01 | 2019-02-12 |
Cold Urticaria (2) · Urticaria (2) · Chronic Inducible Urticaria (1) · Chronic Urticaria (1) · Familial dermographism (1) · Motor Activity (1) · Pruritus (1)
Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Pathological Conditions, Signs and Symptoms (2) · Urticaria (2) · Behavior (1) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Biological Products (1) · Exercise (1) · Omalizumab (1) · dupilumab (1) · ligelizumab (1)
Celldex Therapeutics (1) · Charite University, Berlin, Germany (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · JW Pharmaceutical (1) · Novartis Pharmaceuticals (1) · Sohag University (1) · University Hospital, Montpellier (1)
Germany (4) · Egypt (1) · France (1) · Spain (1)
2017 (1), 2019 (1)